AI assistant
VERACYTE, INC. — Director's Dealing 2019
Jul 1, 2019
31551_dirs_2019-07-01_636d109e-1455-4a35-9a9e-56cfb09830a1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: VERACYTE, INC. (VCYT)
CIK: 0001384101
Period of Report: 2019-06-24
Reporting Person: Hanna John Walter JR (Chief Commercial Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 65357 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $2.4 | 2021-09-19 | Common Stock (11947.0) | Direct | |
| Stock Option (right to buy) | $4.0 | 2023-02-04 | Common Stock (53.0) | Direct | |
| Stock Option (right to buy) | $14.34 | 2024-02-18 | Common Stock (9000.0) | Direct | |
| Stock Option (right to buy) | $8.86 | 2025-03-01 | Common Stock (30000.0) | Direct | |
| Stock Option (right to buy) | $6.45 | 2026-02-28 | Common Stock (55000.0) | Direct | |
| Stock Option (right to buy) | $9.05 | 2027-03-02 | Common Stock (50000.0) | Direct | |
| Stock Option (right to buy) | $5.98 | 2028-03-01 | Common Stock (52500.0) | Direct | |
| Stock Option (right to buy) | $20.21 | 2029-02-27 | Common Stock (60000.0) | Direct |
Footnotes
F1: Includes 8,333 restricted stock units from a grant awarded on March 3, 2017 which vests 1/3 on each annual anniversary, 4,813 restricted stock units from a grant which vested 25% on March 2, 2019 and 3/48 on each quarterly anniversary thereafter, 32,000 restricted stock units awarded on February 28, 2019 which vest 25% on February 28, 2021 and 75% on February 28, 2022 and 8,000 restricted stock units awarded on February 28, 2019 which vests 25% on February 28, 2020 and 3/48 on each quarterly vesting date thereafter. Vesting of restricted stock units is subject to continuing employment of the Reporting person on the vest date.
F2: The option is fully vested.
F3: Includes 25,000 options that vested over a 3 year period. Also includes 30,000 options that became exercisable as to 25% of the shares on March 1, 2017, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
F4: The option became exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
F5: The option became exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
F6: The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.